Keywords: prasugrel, trials, suspended, dosage, issues, japanese, drugmaker

Two prasugrel trials suspended on dosage issues

Article | 29 October 2007

Print This

Japanese drugmaker Daiichi Sankyo and US counterpart Eli Lilly say that enrollment and dosing have been suspended in two small ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in